Hansen Gwenn sold NRIX
June 25, 2026 · Form 4 insider transaction
Hansen Gwenn sold 5,394 shares of Nurix Therapeutics, Inc. at $20.00 per share, a transaction worth $107.9K. The trade was recorded as open-market sale under a pre-scheduled Rule 10b5-1 plan and disclosed on an SEC Form 4, filed 0 days after the transaction.
Direction
Disposed (sell-side)
Shares
5,394
Price
$20.00
Total value
$107.9K
InsiderHansen Gwenn
Role—
SecurityCommon Stock
Transaction codeS: Open-market sale
Transaction dateJune 25, 2026
Filing dateJune 25, 2026
Shares owned after115,005
OwnershipDirect
10b5-1 planYes
AmendedNo
Footnotes
This transaction was effected pursuant to a Rule 10b5-1 trading plan previously adopted by the Reporting Person.